News

Deal Announcements

CardioDx Raises Strategic Venture Capital

Monday, May 17, 2010 5:38:00 AM PDT | VentureDeal Staff
Palo Alto, California  --  Medical device company CardioDx has secured $5 million in additional strategic venture capital.

CardioDx is developing genomic tests to help tailor individualized care for people with cardiovascular diseases.

GE Healthymagination Fund made the investment as part of the fourth round of company funding.  Proceeds purposes from the financing were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1